Label-free quantitative LC-MS proteomics of alzheimer's disease and normally aged human brains

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3053-3067

  Andreev, Victor P ^a,b   Petyuk, Vladislav A ^c   Brewer, Heather M ^c   Karpievitch, Yuliya V ^c   Xie, Fang ^c   Clarke, Jennifer ^a   Camp, David ^c   Smith, Richard D ^c   Lieberman, Andrew P ^d   Albin, Roger L ^d,e   Nawaz, Zafar ^a   El Hokayem, Jimmy ^a   Myers, Amanda J ^a,f  

^a Department of Psychiatry and Behavioral Sciences ^*  (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e VAAAHS   (United States)

^f Division of Neuroscience   (United States)

Author keywords

Alzheimer s disease; bioinformatics; brain; cortical samples; normalization; proteomics

Indexed keywords

PROTEIN; PROTEOME; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ARTICLE; BIOINFORMATICS; BRAIN; CELL DEATH; CLINICAL ARTICLE; CONSENSUS; CONTROLLED STUDY; CYTOSKELETON; ENERGY YIELD; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; AGED; CASE CONTROL STUDY; GENE REGULATORY NETWORK; GENETICS; ISOLATION AND PURIFICATION; MALE; METABOLISM; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; GENE REGULATORY NETWORKS; HUMANS; MALE; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION FACTORS;

EID: 84861832244     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3001546     Document Type: Article

References (89)

1. Evans, D. A.; Funkenstein, H. H.; Albert, M. S.; Scherr, P. A.; Cook, N. R.; Chown, M. J.; Hebert, L. E.; Hennekens, C. H.; Taylor, J. O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported J. Am. Med. Assoc. 1989, 262, 2551-2556
2. Gatz, M.; Pedersen, N. L.; Berg, S.; Johansson, B.; Johansson, K.; Mortimer, J. A.; Posner, S. F.; Viitanen, M.; Winblad, B.; Ahlbom, A. Heritability for Alzheimer's disease: the study of dementia in Swedish twins J. Gerontol., Ser. A 1997, 52, M117-M125
3. Risch, N.; Merikangas, K. The future of genetic studies of complex human diseases Science 1996, 273, 1516-1517
4. Papassotiropoulos, A.; Fountoulakis, M.; Dunckley, T.; Stephan, D. A.; Reiman, E. M. Genetics, transcriptomics and proteomics of Alzheimer's disease J. Clin. Psychiatry 2006, 67, 652-670
5. Lovestone, S.; Guntert, A.; Hye, A.; Lynham, S.; Thambisetty, M.; Ward, M. Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers Expert Rev. Proteomics 2007, 4, 227-238
6. Korolainen, M. A.; Nyman, T. A.; Aittokallio, T.; Pirttila, T. An update on clinical proteomics of Alzheimer's research J. Neurochem. 2010, 112, 1386-1414
7. Cocabelos, R.; Martinez-Bouza, R. Genomics and Pharmacogenomics of Dementia CNS Neurosci. Ther. 2011, 17, 566-576
8. Cummings, J. L. Biomarkers in Alzheimer's disease drug development Alzheimer's Dementia 2011, 7, e13-e44
9. Juhasz, G.; Foldi, I.; Penke, B. Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD Neurochem. Int. 2011, 58, 739-750
10. Davinelli, S.; Intrieri, M.; Russo, C.; Di Constanzo, A.; Zella, D.; Bosco, P.; Scapagnini, G. The "Alzheimer's disease signature" ; potential perspectives for novel biomarkers Immun. Ageing 2011, 8, 7-17
11. Di Domenico, F.; Coccia, R.; Butterfield, D. A.; Perluigi, M. Circulating biomarkers of protein oxidation for Alzheimer's disease: Expectations within limits Biochim. Biophys. Acta 2011, 1814, 1785-1795
12. Finehout, E. J.; Franck, Z.; Choe, L. H.; Relkin, N.; Lee, K. H. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease Ann. Neurol. 2007, 61, 120-129
13. Simonsen, A. H.; McGuire, J.; Hansson, O.; Zetterberg, H.; Podust, V. N.; Davies, H. A. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment Arch. Neurol. 2007, 64, 366-370
14. Simonsen, A. H.; McGuire, J.; Podust, V. N.; Hagnelius, N. O.; Nilsson, T. K.; Kapaki, E. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia Dementia Geriatr. Cognit. Disord. 2007, 24, 434-440
15. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nat. Med. 2007, 13, 1359-1362
16. Palmer, J. C.; Baig, S.; Kehoe, P. G.; Love, S. Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta Am. J. Pathol. 2009, 175, 262-270
17. Xia, Q.; Cheng, D.; Duong, D. M.; Gearing, M.; Lah, J. J.; Levey, A. I.; Peng, J. Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry J. Proteome Res. 2008, 7, 2845-2851
18. Rudrabhatla, P.; Jaffe, H.; Pant, H. C. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs FASEB J. 2011, 11, 3896-3905
19. Di Domenico, F.; Sultana, R.; Barone, E.; Perluigi, M.; Cini, C.; Mancuso, C.; Cai, J.; Pierce, W. M.; Butterfield, D. A. Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects J. Proteomics 2011, 74, 1091-1103
20. Reed, T.; Perluigi, M.; Sultana, R.; Pierce, W. M.; Klein, J. B.; Turner, D. M.; Coccia, R.; Markesbery, W. R.; Butterfield, D. A. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease Neurobiol. Dis. 2008, 30, 107-120
21. Sultana, R.; Butterfield, D. A. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer's disease and mild cognitive impairment J. Bioenerg. Biomembr. 2009, 41, 441-446
22. Charlwood, J.; Dingwalls, C.; Matico, R.; Hussain, I.; Johanson, K.; Moore, S.; Powel, D. J.; Skehel, J. M.; Ratcliffe, S.; Clarke, B.; Trill, J.; Sweitzer, S.; Camilleri, P. Characterization of the glycosylation profiles of Alzheimer's beta-secretase protein asp-2 expressed in variety of cell lines J. Biol. Chem. 2001, 276, 16739-16748
23. Twine, N. A.; Janitz, K.; Wilkins, M. A.; Janitz, M. Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease PloS One 2011, 6, e16266
24. Hata, R.; Masumura, M.; Akatsu, H.; Li, F.; Fujita, H. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray Biochem. Biophys. Res. Commun. 2001, 284, 310-316
25. Ginsberg, S. D.; Crino, P. B.; Hemby, S. E.; Weingarten, J. A.; Lee, V. M. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques Ann. Neurol. 1999, 45, 174-181
26. Larner, A. J.; Doran, M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the preselin-1 gene J. Neurol. 2006, 253, 139-158
27. Folstein, M. F. Heterogeneity of Alzheimer's disease Neurobiol. Aging 1989, 5, 434-435
28. Gygi, S. P.; Rochon, Y.; Franza, B. R. Correlation between protein and mRNA abundance in yeast Mol. Cell. Biol. 1999, 19, 1720-1730
29. Hack, C. J. Integrated transcriptome and proteome data: the challenges ahead Briefings Funct. Genomics Proteomics 2004, 3, 212-219
30. Chen, G.; Gharib, T. G.; Huang, C.-C.; Taylor, J. M. G.; Misek, D. E.; Kardia, S. L. R.; Giordano, T. J.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. M.; Beer, D. G. Discordant protein and mRNA expression in lung adenocarcinomas Mol. Cell. Proteomics 2002, 1, 304-313
31. Ong, S. E.; Mann, M. Mass spectrometry based proteomics turns quantitative Nat. Chem. Biol. 2005, 1, 252-262
32. Cox, J.; Mann, M. Is proteomics a new genomics? Cell 2007, 130, 395-398
33. Ahrens, C. H.; Brunner, E.; Qeli, E.; Basler, K.; Aebersold, R. Generating and navigating proteome maps using mass spectrometry Nat. Rev Mol. Cell. Biol. 2010, 11, 789-801
34. Levin, Y.; Wang, L.; Schwartz, E.; Koethe, D.; Leweke, F. M.; Bahn, S. Global proteomics profiling reveals altered proteomic signature in schizophrenia serum Mol. Psychiatry 2010, 15, 1088-1100
35. Chan, M. K.; Tsang, T. M.; Harris, L. W.; Guest, P. C.; Holmes, E.; Bahn, S. Evidence for disease and antipsychotic medication effects in post mortem brain from schizophrenia patients Mol. Psychiatry 2010, 15, 1-14
36. Michaelevski, I.; Medzihradszky, K. F.; Lynn, A.; Burlingame, A. L.; Fainzilber, M. Axonal transport proteomics reveals mobilization of translation machinery to the lesion site in injured sciatic nerve Mol. Cell. Proteomics 2010, 9, 976-987
37. Burton, E. J.; Barber, R.; Mukaetova-Ladinska, E. B.; Robson, J.; Perry, R. H.; Jaros, E.; Kalaria, R. N.; O'Brien, J. T. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis Brain 2009, 132, 195-203
38. Conrads, T. P.; Anderson, G. A.; Veenstra, T. D.; Pasa-Tolic, L.; Smith., R. D. Utility of accurate mass tags for proteome-wide protein identification Anal. Chem. 2000, 72, 3349-3354
39. Smith, R. D.; Anderson, G. A.; Lipton, M. S.; Pasa-Tolic, L.; Shen, Y.; Conrads, T. P.; Veenstra, T. D.; Udseth, H. R. An accurate mass tag strategy for quantitative and high-throughput proteome measurements Proteomics 2002, 2, 513-523
40. Smith, R. D.; Anderson, G. A.; Lipton, M. S.; Masselon, C. D.; Pasa-Tolic, L.; Shen, Y.; Udseth, H. R. The Use of accurate mass tags for high-throughput microbial proteomics OMICS 2002, 6, 61-90
41. Jaitly, N.; Monroe, M. E.; Petyuk, V. A.; Clauss, T. R. W.; Adkins, J. N.; Smith, R. D. Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline Anal. Chem. 2006, 78, 7397-7409
42. Petyuk, V. A.; Qian, W.-J.; Chin, M. H.; Wang, H.; Livesay, E. A.; Monroe, M. E.; Adkins, J. N.; Jaitly, N.; Anderson, D. J.; Camp, D. G.; Smith, D. J.; Smith, R. D. Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry Genome Res. 2007, 17, 328-336
43. Petyuk, V. A.; Qian, W.; Smith, R. D.; Smith, D. J. Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry Methods 2010, 50, 77-84
44. Wang, W.; Zhou, H.; Lin, H.; Roy, S.; Shaler, T. A.; Hill, L. R.; Norton, S.; Kumar, P.; Anderle, M.; Becker, C. H. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards Anal. Chem. 2003, 75, 4818-4826
45. Silva, J. C.; Denny, R.; Dorschel, C. A.; Gerenstein, M.; Kass, I. J.; Li, G.-Z.; McKenna, T.; Nold, M. J.; Richardson, K.; Young, P.; Geromanos, S. Quantitative proteomic analysis by accurate mass retention time pairs Anal. Chem. 2005, 77, 2187-2200
46. Ferguson, R. E.; Carroll, H. P.; Harris, A.; Maher, E. R.; Selby, P. J.; Banks, R. E. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies Proteomics 2005, 5, 566-571
47. Lim, W. K.; Wang, K.; Lefebvre, C.; Califano, A. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks Bioinformatics 2007, 23, i282-i288
48. Stafford, P. Methods in Microarray Normalization; CRC Press: Boca Raton, 2008.
49. Pritchard, J. K.; Stephens, M.; Rosenberg, N. A.; Donnelly, P. Inference of population structure using multilocus genotype data Genetics 2000, 155, 945-959
50. Falush, D.; Stephens, M.; Pritchard, J. K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies Genetics 2003, 164, 1567-1587
51. Myers, A. J.; Gibbs, J. R.; Webster, J. A.; Rohrer, K. C.; Zhao, A. S.; Marlowe, L. A survey of genetic human cortical gene expression Nat. Genet. 2007, 39, 1494-1499
52. Webster, J. A.; Gibbs, J. R.; Clarke, J.; Ray, M.; Zhang, W.; Holmans, P. Genetic control of human brain transcript expression in Alzheimer's disease Am. J. Hum. Genet. 2009, 84, 445-458
53. Mayampurath, A,M.; Jaitly, N.; Purvine, S. O.; Monroe, M. E.; Auberry, K. J.; Adkins, J. N.; Smith, R. D. DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra Bioinformatics 2008, 24, 1021-1023
54. Petyuk, V. A.; Mayampurath, A. M.; Monroe, M. E.; Polpitiya, A. D.; Purvine, S. O.; Anderson, G. A.; Camp, D. G., 2nd; Smith, R. D. DtaRefinery, a software tool for elimination of systematic errors from parent ion mass measurements in tandem mass spectra data sets Mol. Cell. Proteomics 2010, 9, 486-496
55. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics Methods Mol. Biol. 2010, 604, 55-71
56. Petyuk, V. A.; Qian, W. J.; Smith, R. D.; Smith, D. J. Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry Methods 2010, 50, 77-84
57. Jaitly, N.; Mayampurath, A.; Littlefield, K.; Adkins, J. N.; Anderson, G. A.; Smith, R. D. Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data BMC Bioinf. 2009, 10, 87
58. Monroe, M. E.; Tolic, N.; Jaitly, N.; Shaw, J. L.; Adkins, J. N.; Smith, R. D. Viper: an advanced software package to support high throughput LC-MS peptide identification Bioinformatics 2007, 23, 2021-2023
59. Qian, W. J.; Jacobs, J. M.; Liu, T.; Camp, D. G., 2nd; Smith, R. D. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications Mol. Cell. Proteomics 2006, 5, 1727-44
60. Andreev, V. P.; Dwivedi, R. C.; Paz-Filho, G.; Krokhin, O. V.; Wong, M.-L.; Wilkins, J. A.; Licinio, J. Dynamics of plasma proteome during leptin replacement therapy in genetically-based leptin deficiency Pharmacogenomics J 2011, 11, 162-173
61. Karpievitch, Y. V.; Taverner, T.; Adkins, J. N.; Callister, S. J.; Anderson, G. A.; Smith, R. D.; Dabney, A. R. Normalization of peak intensities in bottom-up MS-based proteomics using singular value decomposition Bioinformatics 2009, 25, 2573-2580
62. Karpievitch, Y. V.; Stanley, J.; Taverner, T.; Huang, J.; Adkins, J. N.; Ansong, C.; Heffron, F.; Metz, T. O.; Qian, W.-J.; Yoon, H.; Smith, R. D.; Dabney, A. R. A statistical framework for protein quantitation in bottom-up MS-based proteomics Bioinformatics 2009, 25, 2028-2034
63. Polpitiya, A. D.; Qian, W. J.; Jaitly, N.; Petyuk, V. A.; Adkins, J. N.; Camp, D. G., 2nd; Anderson, G. A.; Smith, R. D. DAnTE: a statistical tool for quantitative analysis of -omics data Bioinformatics 2008, 24, 1556-1558
64. Storey, J. D. A direct approach to false discovery rates J. R. Statistical Soc., Ser. B 2002, 64, 479-498
65. The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nat. Genet. 2000, 25, 25-29.
66. Subramanian, A.; Tamayoa, P.; Moothaa, V. K.; Mukherjeed, S.; Eberta, B. L.; Gillette, M. A. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 15545-50
67. Zhang, J.; Goodlett, D. R.; Peskind, E. R.; Quinn, J. F.; Zhou, Y.; Wang, Q. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid Neurobiol. Aging 2005, 26, 207-227
68. Zhang, J.; Goodlett, D. R.; Quinn, J. F.; Peskind, E.; Kaye, J. A.; Zhou, Y. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease J. Alzheimers Dis. 2005, 7, 125-133
69. Abdia, F.; Quinn, J. F.; Jankovic, J.; McIntosh, M.; Leverenz, J. B.; Peskind, E. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients withneurodegenerative disorders J. Alzheimers Dis. 2006, 9, 293-348
70. Ho, L.; Sharma, N.; Blackman, L.; Festa, E.; Reddy, G.; Pasinetti, G. M. From proteomics to biomarker discovery in Alzheimer's disease Brain Res. Rev. 2005, 48, 360-369
71. Sultana, R.; Boyd-Kimball, D.; Cai, J.; Pierce, W. M.; Klein, J. B.; Merchant, M. Proteomics analysis of the Alzheimer's disease hippocampal proteome J. Alzheimers Dis. 2007, 11, 153-164
72. Gozal, Y. M.; Duong, D. M.; Gearing, M.; Cheng, C.; Hanfelt, J. J.; Funderburk, C. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease J. Proteome Res. 2009, 8, 5069-5079
73. Tsuji, T.; Shiozaki, A.; Kohno, R.; Yoshizato, K.; Shimohama, S. Proteomic profiling and neurodegeneration in Alzheimer's disease Neurochem. Res. 2002, 27, 1245-1253
74. Emilsson, L.; Saetre, P.; Jazin, E. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling Neurobiol. Dis. 2006, 21, 618-625
75. http://www.genome.jp/kegg/
76. Vogelgesang, S.; Cascorbi, I.; Schroeder, E.; Pahnke, J.; Kroemer, H. K.; Siegmund, W. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics 2002, 12, 535-41
77. Vogelgesang, S.; Warzok, R. W.; Cascorbi, I.; Kunert-Keil, C.; Schroeder, E.; Kroemer, H. K. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease Curr. Alzheimer Res. 2004, 1, 121-5
78. Baig, S.; Joseph, S. A.; Tayler, H.; Abraham, R.; Owen, M. J.; Williams, J. Distribution and expression of picalm in Alzheimer's disease J Neuropathol. Exp. Neurol. 2010, 69, 1071-1077
79. Fu, H.; Subramanian, R. R.; Masters, S. C. 14-3-3proteins: structure, function, and regulation Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617-647
80. Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Hamshere, M. L. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat. Genet. 2009, 41, 1088-1093
81. Lambert, J. C.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; Hiltunen, M. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat. Genet. 2009, 41, 1094-1099
82. Corneveaux, J. J.; Myers, A. J.; Allen, A. N.; Pruzin, J. J.; Ramirez, M. Association of CR1, CLU, and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals Hum. Mol. Genet. 2010, 19, 3295-3301
83. Chiu, Y. H.; Sun, Q.; Chen, Z. J. E1-L2 activates both ubiquitin and FAT10 Mol. Cell 2007, 27, 1014-1023
84. Groettrup, M.; Pelzer, C.; Schmidtke, G.; Hofmann, K. Activating the ubiquitin family: UBA6 challenges the field Trends Biochem. Sci. 2008, 33, 230-237
85. Upadhya, S. C.; Hegde, A. N. Role of the ubiquitin proteasome system in Alzheimer's disease BMC Biochem. 2007, 8 (Suppl 1) S12-19
86. Song, S.; Jung, Y.-K. Alzheimer's disease meets the ubiquitin-proteosome system Trends Mol. Med. 2004, 10, 565-570
87. Serrano-Pozo, A; Frosch, M. P.; Masliah, E.; Hyman, B. T. Neuropathological alterations in Alzheimer's disease. In The Biology of Alzheimer's Disease; Selkoe, D. J.; Mandelkow, E.; Holtzman, D. M., Eds.; CSH Press: Cold Spring Harbor, NY, 2012; pp 43-65.
88. Cahoy, J. D.; Emery, B.; Kaushal, A.; Foo, L. C.; Zamanian, J. L.; Christopherson, K. S. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function J. Neurosci. 2008, 28, 264-278
89. Kiyonami, R.; Schoen, A.; Prakash, A.; Peterman, S.; Zabrouskov, V.; Picotti, P.; Aebersold, R.; Huhmer, A.; Domon, B. Increased selectivity, analytical precision, and throughput in targeted proteomics Mol. Cell. Proteomics 2011, 10, 1-11